| Application no. and date | 22165237.3 (espacenet) (Federated) (European Patent Register), 20190129 | | Patent/reg. no. and date | DK/EP 4043466, 20240821 | | Publication date | 20220817 | | Priority no. and date | US 201862624176 P, 20180131, US 201862672701 P, 20180517, US 201862747736 P, 20181019 | | EP pub. no. and date |
EP 4043466 20220817 | | Effective date | | | Applicant/owner | Mirati Therapeutics, Inc., Route 206 and Province Line Road
Princeton, New Jersey 08543, US | | Applicant ref. no. | V481597DK00 | | Inventor | MARX, Matthew, Arnold,
San Diego 92127, US,
LEE, Matthew, Randolph,
Del Mar 92014, US,
BOBINSKI, Thomas, P.,
San Diego 92122-4647, US,
BURNS, Aaron, Craig,
San Diego 92128, US,
ARORA, Nidhi,
San Diego 92130, US,
CHRISTENSEN, James, Gail,
San Diego 92130, US,
KETCHAM, John. Michael,
San Diego 92111, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) , C07D 487/04 (2006.01) | | Title | PRC2-inhibitorer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
